Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02523014 |
|---|---|
| Brief Title: | Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas |
| First Submitted : | August 11, 2015 |
| First Submitted that Met QC Criteria : | August 12, 2015 |
| First Posted : | August 14, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 8, 2024 |
| Last Update Posted : | April 9, 2024 |